Bridgewater Associates reduced multibillion-dollar positions in S&P 500 index funds during the quarter ended Sept. 30 while adding selected semiconductor, energy, utility, health care and software stocks, according to the hedge fund's latest Form 13F filing. The changes point to a more targeted U.S. equity portfolio without displacing the broad-market funds that remained Bridgewater's two largest disclosed holdings.
The filing reported 974 positions valued at $23.0 billion at the end of September. The SPDR S&P 500 ETF Trust remained Bridgewater's largest disclosed position at $2.595 billion, representing about 11% of the portfolio, despite a reduction of nearly 1.917 million shares during the quarter. That sale lowered the reported value of the position by roughly $1.378 billion.
Bridgewater also cut its second-largest position, the iShares Core S&P 500 ETF, by 1.494 million shares. The holding was valued at $1.155 billion on Sept. 30, or about 5% of the reported portfolio, after a decline of approximately $1.093 billion in market value during the quarter.
The Vanguard S&P 500 ETF was reduced by roughly 382,000 shares, a move that cut its reported value by about $261 million. Taken together, the three ETF reductions account for the most substantial portfolio-level change in the filing: Bridgewater retained sizeable exposure to the U.S. market while moving less capital through broad S&P 500 trackers.
Chip holdings move to the foreground
Nvidia was Bridgewater's third-largest disclosed holding at $614 million, equal to roughly 2.7% of the portfolio. The fund owned 2.688 million shares as of Sept. 30 after reducing the position by about 1.178 million shares during the quarter.
The cut in Nvidia did not signal a broad retreat from semiconductor companies. Bridgewater expanded several other positions across the chip supply chain, including Lam Research, Qualcomm, Micron Technology, Sandisk and Qorvo. The pattern suggests the manager was redistributing exposure among companies with different roles in chip design, memory, manufacturing equipment and communications hardware.
Lam Research became the portfolio's fifth-largest holding, valued at $348 million, or around 1.5% of reported assets. Bridgewater added roughly 122,000 shares during the quarter. Lam supplies equipment used in semiconductor fabrication, placing it closer to the capital-spending cycle of chip manufacturers than designers such as Nvidia or Qualcomm.
Qualcomm was the largest disclosed addition by value. Bridgewater increased the holding by 716,000 shares to 878,000 shares, lifting its reported market value by about $132 million. The fund also raised its AppLovin Class A stake by 536,000 shares to 683,000 shares, a change worth roughly $123 million based on the filing's quarter-end valuation.
Bridgewater added 120,000 Micron shares, bringing the position to 237,000 shares and increasing its value by about $118 million. Sandisk rose by 66,000 shares to 668,000 shares, adding about $115 million in value.
Qorvo saw the largest increase in share count among the named chip additions. Bridgewater expanded its position by more than 1.037 million shares to 1.068 million shares, a change associated with approximately $119 million of additional market value. Qorvo makes radio-frequency and power-management components used in smartphones, communications networks and other connected devices.
Broadcom remained one of Bridgewater's biggest individual stock positions despite a modest trim. The fund held 1.315 million shares worth $462 million, or about 2% of the portfolio, after selling roughly 3,200 shares.
Mega-cap technology and industrials were reduced
Several well-known technology holdings moved in the opposite direction. Bridgewater reduced its Alphabet Class A position by 862,000 shares to 460,000 shares, lowering the reported value by around $314 million. Amazon was cut by 1.055 million shares to 971,000 shares, a reduction of about $241 million in market value.
These reductions, alongside the trimmed Nvidia and Broadcom positions, indicate that the semiconductor additions were selective rather than an across-the-board increase in large technology exposure. Bridgewater's buys favored a mix of component makers and equipment suppliers, while some of the largest internet and platform companies were scaled back.
Industrials recorded the sharpest sector decline in the portfolio, according to the filing data. Union Pacific was Bridgewater's largest complete disposal, with the fund selling its entire 514,000-share stake and removing approximately $140 million from the portfolio's reported value.
Bridgewater also exited Paccar, selling 946,000 shares in a position that had represented about $114 million in market value. Nutanix and S&P Global were likewise eliminated from the disclosed portfolio.
A Form 13F shows certain U.S.-listed long positions held by institutional managers at quarter-end. It does not provide a complete view of a firm's hedges, derivatives, non-U.S. securities, cash holdings or the rationale behind each trade. The filing nevertheless provides a useful snapshot of how Bridgewater altered its publicly reportable equity exposure during the period.
Energy, power and health care additions broaden the portfolio
Bridgewater initiated several new positions outside technology. Occidental Petroleum entered the portfolio at 1.55 million shares, valued at approximately $85.77 million at the end of September. The fund also established a 1.516 million-share stake in Dominion Energy worth about $91.76 million.
The pair gives Bridgewater exposure to two different parts of the energy system: Occidental operates in oil and gas production, while Dominion is a regulated utility with electricity and natural-gas operations. Adding both alongside semiconductor names spreads the portfolio's new positions across the hardware and power requirements associated with data-center expansion, though the filing does not state that this was the firm's investment rationale.
New technology positions included Synaptics, valued at about $78.35 million; cybersecurity company Fortinet, valued at approximately $75.41 million; and Cisco, valued at around $71.20 million. Bridgewater also opened positions in medical-device maker Medtronic and biopharmaceutical company Jazz Pharmaceuticals.
Health care recorded the largest increase in portfolio weighting during the quarter, based on the sector changes cited in the filing data. The additions in Medtronic and Jazz Pharmaceuticals align with that increase, while the exits from Union Pacific and Paccar help explain the reduction in industrial exposure.
Bridgewater's quarter-end holdings show a portfolio that remains anchored by major S&P 500 funds but is placing more of its disclosed equity capital in specific companies. The largest additions favored chip infrastructure, communications components, energy supply, grid-linked utilities and health care, while the largest sales came from broad index products, selected mega-cap technology stocks and industrial companies.
See how shifting from broad indexes to focused themes can work in crypto too—explore TradFi vs DeFi now.
Disclaimer: The content on this page is provided for general informational purposes only and does not represent the views or financial advice of Toobit. We make no guarantees regarding the accuracy or completeness of this information and shall not be held liable for any errors, omissions, or outcomes resulting from its use. Investing in digital assets involves risk; users should independently evaluate their financial situation and the risks involved. For further details, please consult our Terms of Service and Risk Disclosure.
